The Difference Between Sermorelin, Ipamorelin, Tesamorelin, GHRP-6, GHRP-2, and CJC-1295
All these peptides are related to Growth Hormone, but they do not act in the same way. Some directly stimulate the GHRH receptor, while others activate the ghrelin receptor (GHSR-1a). This difference determines the strength of the effect, the duration of action, and how they are used in various research protocols.
Explore all peptides here → Peptides
How GH Peptides Work
Growth hormone is released by the pituitary gland and plays a key role in numerous physiological processes such as:
- tissue regeneration
- fat metabolism
- muscle recovery
- cell growth
- sleep quality
GH release is primarily controlled by two signals:
- GHRH (Growth Hormone Releasing Hormone) – stimulates GH release
- Somatostatin – inhibits GH release
Some peptides act as GHRH analogs and mimic the natural signal from the hypothalamus. Others act as GHRP (Growth Hormone Releasing Peptides), which activate the ghrelin receptor and stimulate GH release through a different mechanism.
The combination of these two mechanisms is why GH peptides are widely studied in the context of:
- body composition
- recovery
- metabolic health
- sleep and regeneration
The Two Main Groups
GHRH Analogs
These peptides mimic the action of Growth Hormone Releasing Hormone. They stimulate the pituitary gland to release growth hormone naturally.
Sermorelin, Tesamorelin, CJC-1295
GHRP / Ghrelin Agonists
This group stimulates the ghrelin receptor (GHSR-1a), which also leads to the release of growth hormone.
Ipamorelin, GHRP-6, GHRP-2
Detailed Information for Each Peptide
Sermorelin
Sermorelin is a synthetic fragment of GHRH (1-29 amino acids) that stimulates the natural release of growth hormone.
It is considered one of the most physiological approaches to activating the GH axis, as it does not replace the hormone directly.
- improved sleep
- recovery support
- body composition
- long-term longevity strategies
Tesamorelin
Tesamorelin is a modified GHRH analog with a stronger and more stable effect on growth hormone release.
It is known for its strong association with reducing visceral fat.
- metabolic health
- reduction of abdominal fat
- improvement of body composition
CJC-1295
CJC-1295 is a long-acting GHRH analog designed to extend the duration of action of the growth hormone-releasing signal.
- longer-lasting GH stimulation
- muscle tissue regeneration
- improved sleep
Ipamorelin
Ipamorelin is a ghrelin receptor agonist and part of the GHRP peptide group.
It is considered one of the most selective peptides in this group.
- post-workout recovery
- improved sleep
- maintenance of muscle mass
GHRP-6
GHRP-6 is one of the first widely used GH secretagogues.
It stimulates the ghrelin receptor and can increase appetite.
- GH stimulation
- increased appetite
- body mass gain
GHRP-2
GHRP-2 is a stronger GHRP peptide than GHRP-6 and stimulates growth hormone release more aggressively.
- strong GH stimulation
- improved recovery
- body composition
Which peptide is used for which purpose
| Peptide | Primary mechanism | Most common research |
|---|---|---|
| Sermorelin | GHRH signal | sleep, recovery |
| Tesamorelin | GHRH analog | visceral fat |
| CJC-1295 | long GH signal | body composition |
| Ipamorelin | ghrelin receptor | recovery |
| GHRP-6 | ghrelin receptor | appetite |
| GHRP-2 | strong GH stimulation | recovery |
Conclusion
These are not six versions of the same thing. They are different tools for stimulating the GH axis. If you are looking for a more physiological approach – Sermorelin. If you are looking for a cleaner GHRP – Ipamorelin. If the focus is on visceral fat – Tesamorelin.
Important: This material is for informational purposes only and does not constitute medical advice.
PEPTIVO • Longevity & Wellness
If you are interested in peptides from a scientific and purely informational perspective
You can visit the PEPTIVO - Longevity & Wellness group on Telegram, where we collect curated research, lifestyle-style explanations, and context (no noise, no sensationalism).
Join the Telegram group* The information is for educational purposes and does not replace medical consultation.